Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Feature
Nature Biotechnology 26, 763–766 (1 July 2008) | doi:10.1038/nbt0708-763
How many patents does a biopharmaceutical company need?
&
Abstract
Biotech companies are a paradox: they attract funding and may be traded on the stock market without necessarily having strong revenue streams. As businesses go, this is unusual and is often understood as arising from the need for many years of research required to bring a biopharmaceutical product to market.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
